1. The Defendant: (a) KRW 10,400,000 to the Plaintiff; and (b) KRW 5% per annum from January 25, 2014 to April 17, 2014 to the Plaintiff.

1. Facts of recognition;

A. On October 15, 2007, the content of the insurance contract (1) B entered into an insurance contract with the Defendant with the Plaintiff and the beneficiary B as follows:

The contents of the insurance terms and conditions in Ⅲ 80,00,000 cancer diagnostic expenses Ⅲ 80,000 cancer diagnostic expenses when the insurance proceeds are bordered at the time of the life-security period for security deposit Ⅲ - 1E 80,000 cancer diagnostic expenses 400,000 cancer surgical expenses Ⅲ - 2E 80,600,000 cancer surgery expenses 400,000 cancer surgery expenses - 400,000 renewed 2E 80,000,000 cancer surgery expenses - 80,000,000 for 25 years.

2. (Definition and Diagnosis Confirmation of "Crance") In this Agreement, the term "Crance" means a disease (see attached Table 4, e.g., e., Table 4) classified as malicious life in the Fourth Standard Disease Classification.

“암”의 진단확정은 해부병리 또는 임상병리의 전문의사 자격증을 가진 자에 의하여 내려져야 하며, 이 진단은 조직(fixed tissue)검사, 미세침흡인검사(fine needle aspiration biopsy) 또는 혈액(hemic system)검사에 대한 현미경 소견을 기초로 하여야 합니다.

4. (Definition and Confirmation of Diagnosis of Boundary Species) In this Agreement, the term “refilled species” refers to diseases (see Attached Table 6, e.g., Table 6, e., Table 6, e.g., Table 6, e., Table 6, e.g., Table 6, e., Table 6) that are classified as either unknown or

“경계성종양”의 진단확정은 해부병리 또는 임상병리의 전문의사 자격증을 가진 자에 의하여 내려져야 하며, 이 진단은 조직(fixed tissue)검사, 미세침흡인검사(fine needle aspiration biopsy) 또는 혈액(hemic system)검사에 대한 현미경 소견을 기초로 하여야 합니다.

[Attachment 4] The diseases classified as cancer stipulated in the terms and conditions of the malicious life classification table mean the following diseases among the Korean Standard Disease Classification Classification (Enforcement No. 2002-1, January 1, 2003 of the Statistics Korea Notice No. 2002-1, January 4, 2003) amended.

classification of the target disease.